📰 Rom News
Page 443 - Rom News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Rom. Real-time updates on events, politics, business and more.
May 25, 2023
UBS is positive on the stock with a Buy rating. The target price has been raised from USD 315 to USD 475. | May 25, 2023
May 25, 2023
FDA Authorized VLN® Products from 22nd Century Group Provide Key Support to Menthol Ban and Reduced Nicotine Content Policies Currently Advancing in the U.S. Decades of Clinical Research Affirm... | May 25, 2023
May 25, 2023
ORLANDO, FL / ACCESSWIRE / May 25, 2023 / Laser Photonics Corporation (NASDAQ:LASE), ("LPC"), a leading global developer of CleanTech laser systems for laser cleaning and other material applications, today
May 25, 2023
The business model will focus on selling 3D bio-printers and bio-inks designed to develop delicious, nutritious, safe, and consistent cultivated meat from ethically harvested cells. 3D... | May 25, 2023
May 25, 2023
- Initial Data from Global, Multiple Ascending Dose Phase 1/2 ACHIEVE Clinical Trial in Myotonic Dystrophy Type 1 Anticipated in the Second Half of 2023 - WALTHAM, Mass., May 25, 2023 -- Dyne... | May 25, 2023
May 25, 2023
This past week, several stories have been published about false allegations from a baseless lawsuit against DoorDash. Lets set the record straight: DoorDash does not charge... | May 25, 2023
May 25, 2023
CALGARY, Alberta, May 25, 2023 -- LithiumBank Resources Corp. is pleased to announce the highlights from the initial Preliminary Economic Assessment for the Boardwalk lithium brine project... | May 25, 2023
May 25, 2023
Extract from Resolution No. 151/2023 of the Budapest Stock Exchange Ltd. The Budapest Stock Exchange Ltd. resolved to resume trading in the... | May 25, 2023
May 25, 2023
Top 10 U.S. builder now selling from the low $300s in Royse City and the high $200s in Dallas DALLAS, May 25, 2023 /PRNewswire/ -- Century Communities, Inc. —a top 10 national homebuilder,... | May 25, 2023
May 25, 2023
Company to Present Interim Analysis Secondary Endpoint Data Including Progression-free Survival from Phase III TIGeR-PaC Study, a Multi-center Open-label Study Evaluating RenovoGem™ to Treat... | May 25, 2023